ANVISA Discusses Normative Instruction for GLP-1 Pen Manipulation

Mon, 20 Apr 2026 16:57:19 +0000
Pharmaceuticals

ANVISA's Collegiate Board will discuss at its April 29 public meeting a proposed normative instruction establishing technical requirements for compounded GLP-1/GIP receptor agonist medications. The instruction covers import procedures, supplier qualification, quality control testing, stability, storage, and transport of active pharmaceutical ingredients for magistral manipulation. The draft is available for public consultation as part of a broader action plan announced April 6, 2026, addressing irregularities in weight-loss pen importation and manipulation.